Get my own profile
Public access
View all6 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Phillip D. ZamoreGretchen Stone Cook Professor of Biomedical Sciences, University of Massachusetts Medical SchoolVerified email at umassmed.edu
- Reynald LescarbeauIntellia TherapeuticsVerified email at intelliatx.com
- Melissa J. MooreModerna Therapeutics/UMass Medical SchoolVerified email at umassmed.edu
- Liang Meng WeePostdoctoral Fellow, University of California, BerkeleyVerified email at berkeley.edu
- Victor SerebrovInstructor, University of Massachusetts Madical SchoolVerified email at umassmed.edu
- Ruchi ShahEli Lilly & Company, Moderna Therapeutics, Northeastern University, Intellia TherapeuticsVerified email at husky.neu.edu
- Myriam AouadiPrincipal Investigator, Karolinska InstitutetVerified email at ki.se
- Sean RyderProfessor of Biochemistry and Molecular Biotechnology, UMass Chan Medical SchoolVerified email at umassmed.edu
- Loic RouxNATAVerified email at natahub.org
- Maire F. OsbornRNA Therapeutics Institute | Univ. of Massachusetts Medical SchoolVerified email at umassmed.edu